Core advisory

Complex Ownership & UBO Transparency

Beneficial ownership resolution to natural-person level across PCCs, PAHVs and multi-jurisdictional trusts — with jurisdictional analysis and escalation protocols.

The problem

Standard CDD breaks down on complex structures. Protected Cell Companies, Private Asset Holding Vehicles and layered multi-jurisdictional trusts are treated as single entities, so independent risk exposures — PEP connections, sanctions nexus, opaque control — sit hidden inside a structure the institution believes it has assessed.

Beneficial ownership transparency is where financial crime risk most often hides in plain sight. The structures that matter — Protected Cell Companies, Private Asset Holding Vehicles, multi-jurisdictional trusts with trustees, protectors and underlying holding layers — are precisely the structures that standard, template-driven CDD is least equipped to assess.

The failure is rarely a lack of diligence. It is a category error: treating a structure that is economically many entities as if it were one customer.

The risk lives in the layers

A PCC with seventeen protected cells is not one risk; it is seventeen. Each cell can carry its own beneficial owners, its own jurisdictional exposure, its own PEP or sanctions nexus — legally ring-fenced from the others. Assess the PCC at entity level and a high-risk cell disappears inside a low-risk average. CCL assesses each cell and each structural layer on its own merits, which is how exposures that standard CDD never surfaced come to light — as they did in this Channel Islands PCC engagement.

Resolution to the natural person, with the rationale

The standard is unambiguous: beneficial ownership must be resolved to identifiable natural persons. The difficulty is doing it across opaque, layered, cross-border structures and documenting the reasoning at every step so the determination is defensible. We trace control and benefit through each layer, resolve to the natural person, and leave an audit trail a regulator or a trustee can follow without gaps.

Where specialist judgement matters

Some findings cannot be handled by template — a sensitive beneficiary arrangement, a PEP connection isolated in a single cell, a jurisdiction with limited transparency. These need analysis and documented rationale, not a tick-box. That specialist judgement, applied structure by structure, is what turns a stalled UBO problem into a resolved, regulator-ready position.

The CCL approach

  1. 01

    Map the structure as it really is

    We unpick the legal architecture — cells, sub-funds, holding layers, trustee and protector arrangements — to establish where control and benefit actually sit, not where the account-opening form says they sit.

  2. 02

    Resolve to the natural person

    Beneficial ownership is traced to identifiable natural persons across every layer and jurisdiction, with the rationale and evidence documented at each step.

  3. 03

    Assess each cell or layer independently

    PCC cells and structure layers are analysed on their own risk merits — PEP exposure, sanctions, jurisdiction — rather than absorbed into a single entity-level rating.

  4. 04

    Escalate and document

    PEP and high-risk findings are escalated through a defined protocol, with a full audit trail and re-documentation that withstands regulatory and trustee scrutiny.

Quantified outcomes

17 cellsAnalysed independently in one PCC portfolio
3PEP escalations surfaced and documented
100%UBO resolution to natural-person level
6 weeksResolved where internal teams had stalled for 2 years

Frequently asked questions

What makes PCCs and PAHVs so difficult for standard CDD?

A Protected Cell Company is legally one entity but economically many: each cell can have entirely different beneficial owners, risk profiles and PEP or sanctions exposures, ring-fenced from the others. Treating the PCC as a single customer means a high-risk cell can hide behind a low-risk core. The same logic applies to PAHVs and layered trust structures — the risk lives in the layers, not the wrapper.

Can you resolve ownership where our internal team could not?

Frequently. In one Channel Islands engagement we resolved a PCC portfolio that internal teams had been unable to complete for over two years — to 100% natural-person UBO, fully documented and regulator-ready, within six weeks. The blocker is usually specialist structural knowledge, not effort.

How do you handle sensitive beneficiary arrangements?

Some arrangements — for example a minor beneficiary, or a politically exposed connection within a single cell — require specialist analysis and careful documentation rather than a standard template. We assess these on their specific legal and risk merits and document the rationale so the treatment is defensible.

Related case studies

See it in practice

Related insights

Read the thinking

Speak to the practice

Before it becomes a regulatory finding, make it a closed action.

A short, confidential advisory call to pressure-test where your KYC, AML, sanctions or risk-classification framework is exposed — and what a defensible fix looks like.